Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model

[1]  J. DiGiovanni,et al.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis , 2011, Molecular carcinogenesis.

[2]  B. Aggarwal,et al.  Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals , 2010, Cancer and Metastasis Reviews.

[3]  S. Shukla,et al.  Apigenin: A Promising Molecule for Cancer Prevention , 2010, Pharmaceutical Research.

[4]  S. Freier,et al.  Antisense oligonucleotide targeting of insulin‐like growth factor‐1 receptor (IGF‐1R) in prostate cancer , 2010, The Prostate.

[5]  R. Goldbohm,et al.  Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the Netherlands Cohort Study , 2009, International journal of cancer.

[6]  M. Gadelha,et al.  IGF-I, insulin and prostate cancer. , 2009, Arquivos brasileiros de endocrinologia e metabologia.

[7]  B. Grzybowski,et al.  The Chemopreventive Bioflavonoid Apigenin Inhibits Prostate Cancer Cell Motility through the Focal Adhesion Kinase/Src Signaling Mechanism , 2009, Cancer Prevention Research.

[8]  Johann S de Bono,et al.  Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer , 2009, Clinical Cancer Research.

[9]  Pixu Liu,et al.  Targeting the phosphoinositide 3-kinase pathway in cancer , 2009, Nature Reviews Drug Discovery.

[10]  S. Shukla,et al.  Apigenin suppresses insulin‐like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study , 2009, Molecular carcinogenesis.

[11]  S. Shukla,et al.  Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: an in vitro and in vivo study. , 2008, Carcinogenesis.

[12]  K. Ahmed,et al.  Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells , 2008, Molecular and Cellular Biochemistry.

[13]  B. Rosner,et al.  A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer , 2007, International journal of cancer.

[14]  M. Resnick,et al.  Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. , 2007, Cancer research.

[15]  F. Berrino,et al.  Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. , 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  S. Shukla,et al.  Apigenin-induced Cell Cycle Arrest is Mediated by Modulation of MAPK, PI3K-Akt, and Loss of Cyclin D1 Associated Retinoblastoma Dephosphorylation in Human Prostate Cancer Cells , 2007, Cell cycle.

[17]  D. Spandidos,et al.  Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. , 2006, International journal of oncology.

[18]  M. Slomiany,et al.  Hypoxia-Inducible Factor-1-Dependent and -Independent Regulation of Insulin-Like Growth Factor-1-Stimulated Vascular Endothelial Growth Factor Secretion , 2006, Journal of Pharmacology and Experimental Therapeutics.

[19]  B. Lokeshwar,et al.  Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence? , 2006, Urologic oncology.

[20]  Han You,et al.  Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. , 2006, Genes & development.

[21]  Anil Mishra,et al.  Up‐regulation of insulin‐like growth factor binding protein‐3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Maria Parpinel,et al.  Flavonoids and Breast Cancer Risk in Italy , 2005, Cancer Epidemiology Biomarkers & Prevention.

[23]  V. Adhami,et al.  Oral Consumption of Green Tea Polyphenols Inhibits Insulin-Like Growth Factor-I–Induced Signaling in an Autochthonous Mouse Model of Prostate Cancer , 2004, Cancer Research.

[24]  F. Miró,et al.  Unbalanced activation of ERK1/2 and MEK1/2 in apigenin-induced HeLa cell death. , 2004, Experimental cell research.

[25]  T. Byzova,et al.  Metastatic Properties of Prostate Cancer Cells are Controlled by VEGF , 2004, Cell communication & adhesion.

[26]  Myoung H. Kim.  Flavonoids inhibit VEGF/bFGF‐induced angiogenesis in vitro by inhibiting the matrix‐degrading proteases , 2003, Journal of cellular biochemistry.

[27]  Tsuey-Ming Chen,et al.  Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model , 2003, The Prostate.

[28]  L. Bégin,et al.  Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 for prostate cancer detection in patients undergoing prostate biopsy. , 2002, The Journal of urology.

[29]  M. Kattan,et al.  Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  J. Oh,et al.  Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase. , 2001, Cancer research.

[31]  J. Jorcano,et al.  Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  O. Cussenot,et al.  VEGF overexpression in clinically localized prostate tumors and neuropilin‐1 overexpression in metastatic forms , 2000, International journal of cancer.

[33]  M B Katan,et al.  Dietary flavonoids: intake, health effects and bioavailability. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[34]  B. Foster,et al.  The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. , 1999, Cancer research.

[35]  C. Mantzoros,et al.  Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. , 1998, Journal of the National Cancer Institute.

[36]  Y. Wong,et al.  Sex hormone‐induced prostatic carcinogenesis in the Noble rat: The role of insulin‐like growth factor‐1 (IGF‐1) and vascular endothelial growth factor (VEGF) in the development of prostate cancer , 1998, The Prostate.

[37]  C. Bucana,et al.  Regulation of distinct steps of angiogenesis by different angiogenic molecules. , 1998, International journal of oncology.

[38]  Meir J. Stampfer,et al.  Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study , 1998 .

[39]  Z. Kelman.  PCNA: structure, functions and interactions , 1997, Oncogene.

[40]  R. Geahlen,et al.  Inhibition of protein-tyrosine kinase activity by flavanoids and related compounds. , 1989, Journal of natural products.

[41]  J. Thrasher,et al.  Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. , 1996, The Journal of clinical endocrinology and metabolism.